Abstract

Objective To observe the efficacy of medilac-vita combined with smectite powder in treatment of neonatal jaundice.Methods One hundred and twenty patients were randomly divided into two groups,the treatment group (60 patients) were treated in the conventional therapy plus medilac-vita and smectite powder oral; the control group(60 patients) were treated with conventional therapy.Every 24 h with trace bilirubin measurement of serum bilirubin; When serum bilirubin drop to 119.7 μmol/L below the end of treatment,observation index for the two groups were treated daily bilirubin values and decreased time spent.Results The average daily treatment group decreased bilirubin value was greater than the control group,the difference was statistically significant ( t=3.52,P<0.05).Course of the treatment group was significantly shorter than the control group,the difference was statistically significant (t=4.58,P<0.05).Conclusions Medilac-vita combined with smectite powder on neonatal jaundice,bilirubin can increase the average daily decline in value and used to shorten treatment time,the long-term effects need further study and discussion. Key words: Medilac-vita; Smectite; Newborn; Jaundice

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.